| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
|
Wu T.-C.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
|
Wu T.-C.;Ling M.;Slater L.A.;He L.;WEN-FANG CHENG;Hung C.-F.;Hsu K.-F.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Slater L.A.; Ling M.; Wu T.-C.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:44Z |
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene
|
Wu T.-C.;Ling M.;Rice C.M.;He L.;Hsu K.-F.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:42Z |
Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects
|
Ling M.; Wu T.C.; Wu T.C.;Ling M.;He L.;Hsu K.F.;Pai S.I.;Hung C.F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L.; Ling M.; Wu T.C.; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L. |
| 臺大學術典藏 |
2020-02-06T05:22:40Z |
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
|
Wu T.-C.;Ling M.;Slater L.A.;Polo J.M.;He L.;Chai C.-Y.;Hsu K.-F.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:39Z |
Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes
|
Wu T.-C.;Lin C.-T.;Juang J.;Ling M.;He L.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Ling M.; Juang J.; Lin C.-T.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; He L.; Ling M.; Juang J.; Lin C.-T.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:38Z |
CD8+ T cells, NK cells and IFN-�^ are important for control of tumor with downregulated MHC class I expression by DNA vaccination
|
Wu T.-C.;Lin C.T.;He L.;Juang J.;Ling M.;Lin K.Y.;Hung C.F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C.; WEN-FANG CHENG; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:37Z |
Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways
|
Hsieh C.-Y.;Chen C.-A.;Wu T.-C.;He L.;Chang M.-C.;Su Y.-N.;Lee C.-N.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Lee C.-N.; Su Y.-N.; Chang M.-C.; He L.; Wu T.-C.; Chen C.-A.; Hsieh C.-Y.; WEN-FANG CHENG; Hung C.-F.; Lee C.-N.; Su Y.-N.; Chang M.-C.; He L.; Wu T.-C.; Chen C.-A.; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-02-06T05:22:31Z |
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
|
Wu T.-C.;Hsieh C.-Y.;Boyd D.A.K.;Chai C.-Y.;Su Y.-N.;Lee C.-N.;Chen C.-A.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:27Z |
Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity
|
Chen C.-A.;Hsieh C.-Y.;Wu T.-C.;Hung C.-F.;Polo J.M.;Chang M.-C.;Chai C.-Y.;Su Y.-N.;Lee C.-N.;WEN-FANG CHENG; WEN-FANG CHENG; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Chang M.-C.; Polo J.M.; Hung C.-F.; Wu T.-C.; Hsieh C.-Y.; Chen C.-A.; WEN-FANG CHENG; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Chang M.-C.; Polo J.M.; Hung C.-F.; Wu T.-C.; Hsieh C.-Y.; Chen C.-A. |
| 臺大學術典藏 |
2020-02-06T05:22:24Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.;Wang T.-L.;Shih I.-M.;Hsieh C.-Y.;Tseng W.-Y.I.;Su Y.-N.;Lee C.-N.;Chen C.-A.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:21:59Z |
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFN�^
|
Roden R.B.S.; Wu T.-C.; Trimble C.L.; Hung C.-F.; Soong R.-S.; Song L.; Trieu J.; Knoff J.; He L.; Tsai Y.-C.; Huh W.; Chang Y.-N.; WEN-FANG CHENG; Roden R.B.S.; Wu T.-C.; Trimble C.L.; Hung C.-F.; Hung C.-F.;Trimble C.L.;Wu T.-C.;Roden R.B.S.;WEN-FANG CHENG;Chang Y.-N.;Huh W.;Tsai Y.-C.;He L.;Knoff J.;Trieu J.;Song L.;Soong R.-S.; Soong R.-S.; Song L.; Trieu J.; Knoff J.; He L.; Tsai Y.-C.; Huh W.; Chang Y.-N.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-01-22T07:50:51Z |
Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways
|
Cheng W.-F.;Hung C.-F.;Lee C.-N.;Su Y.-N.;Chang M.-C.;He L.;Wu T.-C.;Chi-An Chen;Hsieh C.-Y.; Cheng W.-F.; Hung C.-F.; Lee C.-N.; Su Y.-N.; Chang M.-C.; He L.; Wu T.-C.; CHI-AN CHEN; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-01-22T07:50:50Z |
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
|
Cheng W.-F.;Hung C.-F.;Chi-An Chen;Lee C.-N.;Su Y.-N.;Chai C.-Y.;Boyd D.A.K.;Hsieh C.-Y.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; CHI-AN CHEN; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C. |
| 臺大學術典藏 |
2020-01-22T07:50:45Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Cheng W.-F.;Hung C.-F.;Chai C.-Y.;Chi-An Chen;Lee C.-N.;Su Y.-N.;Tseng W.-Y.I.;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; Chai C.-Y.; CHI-AN CHEN; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2020-01-17T07:44:13Z |
Study and application of underwater noise impact in coastal region off western Taiwan
|
Cheng, Y.-C.; Lin, S.-F.; Chang, Y.-Y.; Chen, C.-F.; Hung, C.-F.; Lin, B.-J.; CHI-FANG CHEN |
| 國立成功大學 |
2020 |
When dragon meets garuda in hutan belantara energy
|
Isnadi, Y.;Hung, C.-F. |
| 國立成功大學 |
2019 |
The effects of alpha asymmetry and high-beta down-training neurofeedback for patients with the major depressive disorder and anxiety symptoms
|
Wang, S.-Y.;Lin, I.-M.;Fan, S.-Y.;Tsai, Y.-C.;Yen, C.-F.;Yeh, Yeh Y.-C.;Huang, M.-F.;Lee, Y.;Chiu, N.-M.;Hung, C.-F.;Wang, P.-W.;Liu, T.-L.;Lin, H.-C. |
| 臺大學術典藏 |
2018-09-10T07:23:25Z |
Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives
|
Lin, K.-W.;Fang, S.-C.;Hung, C.-F.;Shieh, B.-J.;Yang, S.-C.;Teng, C.-M.;Lin, C.-N.; CHE-MING TENG |
| 臺大學術典藏 |
2018-09-10T05:51:42Z |
Synthesis of Ag nanospheres particles in ethylene glycol by electrochemical-assisted polyol process
|
Lim, P. Y.;Liu, R. S.;She, P. L.;Hung, C. F.;Shih, H. C.; Lim, P. Y.; Liu, R. S.; She, P. L.; Hung, C. F.; Shih, H. C.; RU-SHI LIU |
| 臺大學術典藏 |
2018 |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Chiun Hsu;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Chiun Hsu; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2018 |
SIRveNIB: Selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma
|
Ng D.C.E.; Goh B.K.P.; Lo R.H.G.; Tay K.H.; Goh A.S.W.; Low A.S.-C.; Thng C.-H.; Kok K.Y.Y.; Bartlett A.; PO-CHIN LIANG; Chow P.K.H.; Gandhi M.; Tan S.-B.; Khin M.W.; Khasbazar A.; Ong J.; Choo S.P.; Cheow P.C.; Chotipanich C.; Lim K.; Lesmana L.A.; Manuaba T.W.; Yoong B.K.; Raj A.; Law C.S.; Cua I.H.Y.; Lobo R.R.; Teh C.S.C.; Kim Y.H.; Jong Y.W.; Han H.-S.; Bae S.-H.; Yoon H.-K.; Lee R.-C.; Hung C.-F.; Peng C.-Y.; Gebski V.; Mak K.S.W.; Soo K.C.; Liew W.M.; Lekurwale G.; Chow P.K.H.;Gandhi M.;Tan S.-B.;Khin M.W.;Khasbazar A.;Ong J.;Choo S.P.;Cheow P.C.;Chotipanich C.;Lim K.;Lesmana L.A.;Manuaba T.W.;Yoong B.K.;Raj A.;Law C.S.;Cua I.H.Y.;Lobo R.R.;Teh C.S.C.;Kim Y.H.;Jong Y.W.;Han H.-S.;Bae S.-H.;Yoon H.-K.;Lee R.-C.;Hung C.-F.;Peng C.-Y.;Po-Chin Liang;Bartlett A.;Kok K.Y.Y.;Thng C.-H.;Low A.S.-C.;Goh A.S.W.;Tay K.H.;Lo R.H.G.;Goh B.K.P.;Ng D.C.E.;Lekurwale G.;Liew W.M.;Gebski V.;Mak K.S.W.;Soo K.C. |
| 臺大學術典藏 |
2018 |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
PO-HUANG LEE; Wu C.-C.; Huo T.-I.; Liao L.-Y.; Huang S.-F.; Hung C.-F.; Yang S.-S.; Chen R.-C.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Po-Huang Lee;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 國立成功大學 |
2018 |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu, S.-N.;Wang, J.-H.;Su, C.-W.;Wang, T.-E.;Dai, C.-Y.;Chen, Chen C.-H.;Chen, R.-C.;Yang, S.-S.;Hung, C.-F.;Huang, S.-F.;Liao, Liao L.-Y.;Huo, T.-I.;Wu, C.-C.;Lee, P.-H.;Ting, C.-T.;Lee, W.-C.;Chau, G.-Y.;Wang, C.-C.;Lee, K.-T.;Huang, Y.-H.;Ho, M.-C.;Lin, S.-M.;Huang, G.-T.;Chen, K.-Y.;Lin, X.-Z.;Hwang, J.-I.;Chiou, Y.-Y.;Wang, C.-K.;Hu, J.-T.;Chen, S.-C.;Liang, P.-C.;Lee, R.-C.;Wu, D.-K.;Lin, C.-Y.;Lin, C.-C.;Cheng, A.-L.;Hsu, C.;Chao, Y.;Chen, L.-T.;Wang, P.-M.;Wang, P.-M.;Hong, J.-H.;Hsu, Hsu H.-C.;Chen, S.-W.;Leung, S.W.;Cheng, J.C.-H.;Wu, J.-C.;Wu, C.-Y.;Hsu, Y.-C.;Hsu, C.-W.;Ni, Y.-H.;Lin, C.-L.;group, Local ablation;group, Surveillance;group, Diagnosis;group, Staging;group, Surgery;group, TACE/TARE/HAI;group, Target therapy/systemic therapy;group, Radiotherapy;group, Prevention;group, Drafting |
| 國立成功大學 |
2018 |
The Chinese version of the Brief Assessment of Cognition in Affective Disorders: normative data of a Mandarin-speaking population
|
Lee, C.-Y.;Lee, S.-Y.;Huang, Y.-C.;Hung, C.-F.;Lee, Y.;Lee, M.-I.;Wang, L.-J. |
